Results 161 to 170 of about 165,216 (289)
This study proposes a novel HCC therapy using CA‐4S2@ES‐Cu nanomedicines to amplify cuproptosis, enhancing chemotherapy and immunotherapy. CA‐4 and ES‐Cu synergistically inhibit tumor growth, induce immune responses, and reverse the immunosuppressive microenvironment, offering an effective multidimensional therapeutic strategy for HCC treatment ...
Yingjie Zeng+16 more
wiley +1 more source
Efficacy of double filtration plasmapheresis combined with immunosuppressive agents in the treatment of severe lupus nephritis. [PDF]
Lin X+5 more
europepmc +1 more source
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression". [PDF]
Roberts MB, Fishman JA.
europepmc +1 more source
The potential of antibody‐based immunosuppressive agents for corneal transplantation [PDF]
Michael Thiel+2 more
openalex +1 more source
Adopting a paradigm shift that transforms a known health hazard as a potential therapeutic asset, a novel therapeutic strategy is set out to investigate for inflammatory conditions by leveraging immunosuppressive properties of UV‐irradiated keratinocytes.
Lu Liu+16 more
wiley +1 more source
Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study. [PDF]
Cho SK+6 more
europepmc +1 more source
Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents. [PDF]
Munshi MA+3 more
europepmc +1 more source
Thrombotic Thrombocytopenic Purpura (TTP): Initial Treatment with Plasma Exchange Plus Steroids and Immunosuppressive Agents for Relapsing Cases [PDF]
Chung‐Wei Yang+5 more
openalex +1 more source